These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 20118585

  • 1. Enhancement of wettability and dissolution properties of cilostazol using the supercritical antisolvent process: effect of various additives.
    Kim MS, Kim JS, Hwang SJ.
    Chem Pharm Bull (Tokyo); 2010 Feb; 58(2):230-3. PubMed ID: 20118585
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Enhanced dissolution of megestrol acetate microcrystals prepared by antisolvent precipitation process using hydrophilic additives.
    Cho E, Cho W, Cha KH, Park J, Kim MS, Kim JS, Park HJ, Hwang SJ.
    Int J Pharm; 2010 Aug 30; 396(1-2):91-8. PubMed ID: 20558265
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Comparative physicochemical characterization of phospholipids complex of puerarin formulated by conventional and supercritical methods.
    Li Y, Yang DJ, Chen SL, Chen SB, Chan AS.
    Pharm Res; 2008 Mar 30; 25(3):563-77. PubMed ID: 17828444
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Investigation of nanosized crystalline form to improve the oral bioavailability of poorly water soluble cilostazol.
    Miao X, Sun C, Jiang T, Zheng L, Wang T, Wang S.
    J Pharm Pharm Sci; 2011 Mar 30; 14(2):196-214. PubMed ID: 21733409
    [Abstract] [Full Text] [Related]

  • 9. Can crystal engineering be as beneficial as micronisation and overcome its pitfalls?: A case study with cilostazol.
    Sai Gouthami K, Kumar D, Thipparaboina R, Chavan RB, Shastri NR.
    Int J Pharm; 2015 Aug 01; 491(1-2):26-34. PubMed ID: 26068197
    [Abstract] [Full Text] [Related]

  • 10. Preparation and pharmaceutical characterization of amorphous cefdinir using spray-drying and SAS-process.
    Park J, Park HJ, Cho W, Cha KH, Kang YS, Hwang SJ.
    Int J Pharm; 2010 Aug 30; 396(1-2):239-45. PubMed ID: 20599602
    [Abstract] [Full Text] [Related]

  • 11. Simultaneous production and co-mixing of microparticles of nevirapine with excipients by supercritical antisolvent method for dissolution enhancement.
    Sanganwar GP, Sathigari S, Babu RJ, Gupta RB.
    Eur J Pharm Sci; 2010 Jan 31; 39(1-3):164-74. PubMed ID: 19961931
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Improving the wetting and dissolution of ibuprofen using solventless co-milling.
    Varghese S, Ghoroi C.
    Int J Pharm; 2017 Nov 25; 533(1):145-155. PubMed ID: 28951348
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Preparation, characterization and in vivo evaluation of amorphous atorvastatin calcium nanoparticles using supercritical antisolvent (SAS) process.
    Kim MS, Jin SJ, Kim JS, Park HJ, Song HS, Neubert RH, Hwang SJ.
    Eur J Pharm Biopharm; 2008 Jun 25; 69(2):454-65. PubMed ID: 18359211
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.